1 - 25 of 47 results for author:"Mason P.J." in Literature citations
Results Customize
› Repeat search in UniProtKB (19)
| Protein tyrosine phosphatase mu regulates glioblastoma cell growth and survival in vivo. Kaur H., Burden-Gulley S.M., Phillips-Mason P.J., Basilion J.P., Sloan A.E., Brady-Kalnay S.M. Neuro-oncology 14:561-573(2012) · Mapped (7) |
| Cadherin-11, a marker of the mesenchymal phenotype, regulates glioblastoma cell migration and survival in vivo. Kaur H., Phillips-Mason P.J., Burden-Gulley S.M., Kerstetter-Fogle A.E., Basilion J.P., Sloan A.E., Brady-Kalnay S.M. Mol. Cancer Res. 10:293-304(2012) · Mapped (5) |
| 3'UTR-truncated Hmga2 cDNA causes MPN-like hematopoiesis by conferring a clonal growth advantage at the level of HSC in mice. Ikeda K., Mason P.J., Bessler M. Blood 117:5860-5869(2011) · Mapped (7) |
| SnoRNA microarray analysis reveals changes in H/ACA and C/D RNA levels caused by dyskerin ablation in mouse liver. Ge J., Crosby S.D., Heinz M.E., Bessler M., Mason P.J. Biochem. J. 429:33-41(2010) · Mapped (9) |
| Dyskerin ablation in mouse liver inhibits rRNA processing and cell division. Ge J., Rudnick D.A., He J., Crimmins D.L., Ladenson J.H., Bessler M., Mason P.J. Mol. Cell. Biol. 30:413-422(2010) · Mapped (9) |
| Anomalous electrophoretic migration of newly synthesized ribosomal RNAs and their precursors from cells with DKC1 mutations. Gu B.W., Zhao C., Fan J.M., Dai Q., Bessler M., Mason P.J. FEBS Lett. 583:3086-3090(2009) · Mapped (9) |
| Proteolytic cleavage of protein tyrosine phosphatase mu regulates glioblastoma cell migration. Burgoyne A.M., Phillips-Mason P.J., Burden-Gulley S.M., Robinson S., Sloan A.E., Miller R.H., Brady-Kalnay S.M. Cancer Res. 69:6960-6968(2009) · Mapped (7) |
| Variable expression of Dkc1 mutations in mice. He J., Gu B.W., Ge J., Mochizuki Y., Bessler M., Mason P.J. Genesis 47:366-373(2009) · Mapped (9) |
| PTPmu suppresses glioma cell migration and dispersal. Burgoyne A.M., Palomo J.M., Phillips-Mason P.J., Burden-Gulley S.M., Major D.L., Zaremba A., Robinson S., Sloan A.E., Vogelbaum M.A., Miller R.H. et al. Neuro-oncology 11:767-778(2009) · Mapped (7) |
| TINF2 mutations in children with severe aplastic anemia. Du H.Y., Mason P.J., Bessler M., Wilson D.B. Pediatr Blood Cancer 52:687-687(2009) · Mapped (5) |
| BCCIP associates with the receptor protein tyrosine phosphatase PTPmu. Phillips-Mason P.J., Mourton T., Major D.L., Brady-Kalnay S.M. J. Cell. Biochem. 105:1059-1072(2008) · Mapped (10) |
| The role of human ribosomal proteins in the maturation of rRNA and ribosome production. Robledo S., Idol R.A., Crimmins D.L., Ladenson J.H., Mason P.J., Bessler M. RNA 14:1918-1929(2008) |
| A pathogenic dyskerin mutation impairs proliferation and activates a DNA damage response independent of telomere length in mice. Gu B.W., Bessler M., Mason P.J. Proc. Natl. Acad. Sci. U.S.A. 105:10173-10178(2008) · Mapped (25) |
| Identification of ATPases pontin and reptin as telomerase components essential for holoenzyme assembly. Venteicher A.S., Meng Z., Mason P.J., Veenstra T.D., Artandi S.E. Cell 132:945-957(2008) · Mapped (8) |
| Complex inheritance pattern of dyskeratosis congenita in two families with 2 different mutations in the telomerase reverse transcriptase gene. Du H.Y., Pumbo E., Manley P., Field J.J., Bayliss S.J., Wilson D.B., Mason P.J., Bessler M. Blood 111:1128-1130(2008) · UniProtKB (1) |
| G6PD deficiency: the genotype-phenotype association. Mason P.J., Bautista J.M., Gilsanz F. Blood Rev. 21:267-283(2007) · Mapped (7) |
| A four base pair insertion in exon 1 of the RPS19 gene is a common polymorphism in African-Americans. Huang Q., Robledo S., Wilson D.B., Bessler M., Mason P.J. Br. J. Haematol. 135:745-746(2006) · Mapped (3) |
| The receptor protein-tyrosine phosphatase PTPmu interacts with IQGAP1. Phillips-Mason P.J., Gates T.J., Major D.L., Sacks D.B., Brady-Kalnay S.M. J. Biol. Chem. 281:4903-4910(2006) · Mapped (15) |
| Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation. Vulliamy T.J., Marrone A., Knight S.W., Walne A., Mason P.J., Dokal I. Blood 107:2680-2685(2006) · UniProtKB (1) |
| Mutations in the reverse transcriptase component of telomerase (TERT) in patients with bone marrow failure. Vulliamy T.J., Walne A., Baskaradas A., Mason P.J., Marrone A., Dokal I. Blood Cells Mol. Dis. 34:257-263(2005) · UniProtKB (1) |
| Mutations of the SBDS gene are present in most patients with Shwachman-Diamond syndrome. Woloszynek J.R., Rothbaum R.J., Rawls A.S., Minx P.J., Wilson R.K., Mason P.J., Bessler M., Link D.C. Blood 104:3588-3590(2004) · Mapped (1) |
| Mouse dyskerin mutations affect accumulation of telomerase RNA and small nucleolar RNA, telomerase activity, and ribosomal RNA processing. Mochizuki Y., He J., Kulkarni S., Bessler M., Mason P.J. Proc. Natl. Acad. Sci. U.S.A. 101:10756-10761(2004) · UniProtKB (1) · Mapped (8) |
| Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency. Draper N., Walker E.A., Bujalska I.J., Tomlinson J.W., Chalder S.M., Arlt W., Lavery G.G., Bedendo O., Ray D.W., Laing I. et al. |
| Murine hexose-6-phosphate dehydrogenase: a bifunctional enzyme with broad substrate specificity and 6-phosphogluconolactonase activity. Clarke J.L., Mason P.J. Arch. Biochem. Biophys. 415:229-234(2003) · Mapped (6) |
| Combined glucose-6-phosphate dehydrogenase and glucosephosphate isomerase deficiency can alter clinical outcome. Clarke J.L., Vulliamy T.J., Roper D., Mesbah-Namin S.A., Wild B.J., Walker J.I., Will A.M., Bolton-Maggs P.H., Mason P.J., Layton D.M. Blood Cells Mol. Dis. 30:258-263(2003) · Mapped (11) |